Merkel Cell Carcinoma: An Update and Immunotherapy
Merkel cell carcinoma (MCC) is a rare but aggressive skin cancer with frequent metastasis and death. MCC has a mortality rate of 30%, making it more lethal than malignant melanoma, and incidence of MCC has increased almost fourfold over the past 20 years in the USA. MCC has long been considered to b...
Main Author: | Hiroshi Uchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fonc.2018.00048/full |
Similar Items
-
Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale?
by: Enrica Teresa Tanda, et al.
Published: (2021-09-01) -
Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma
by: Glenn J. Hanna, et al.
Published: (2020-06-01) -
Merkel cell carcinoma: multiple primary skin lesions in the lower limb
by: Bruna Margatho Elias, et al.
Published: (2022-12-01) -
Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy
by: Natalie J. Miller, et al.
Published: (2018-11-01) -
A clinical case of Merkel cell carcinoma
by: R. V. Saranyuk, et al.
Published: (2023-06-01)